Verwandte Artikel zu Immune Deficiency and Cancer: Epstein-Barr Virus and...
Inhaltsangabe
The discoveries of Burkitt, Epstein, and Henle have laid the foundation for continuing generation of information regarding the mechanisms of induction of diseases by Epstein-Barr virus. The discovery of the virus two decades ago resulted from clinical and basic science collaborative studies on Burkitt lymphoma. Subse quently, nasopharyngeal carcinoma and infectious mononucleosis have been linked etiologically with the virus. During the first decade of research following the discovery of the virus, the mechanisms for the induction of BL, NPC, and IM were sought. At that time one prevailing view was that individual oncogenic strains of EBV were responsible for the different disorders. Paralleling the development of immunology in the 1970's was the accrual of knowledge about immunological events occurring during IM. These studies suggest that immune defense mechanisms deter mine the outcome of this viral infection rather than different viral strains. During the early 1970's, Starzl and Penn and Gatti and Good had noted an increased frequency of malignancy in renal allograft recipients and children with primary immune deficiency disorders, respectively. These observations provoked investigators to restudy the role of immune surveillance against malignancy. At that time immune surveillance was thought to occur against tumor-specific antigens; thereby neoplasms were eliminated.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
Reseña del editor
The discoveries of Burkitt, Epstein, and Henle have laid the foundation for continuing generation of information regarding the mechanisms of induction of diseases by Epstein-Barr virus. The discovery of the virus two decades ago resulted from clinical and basic science collaborative studies on Burkitt lymphoma. Subse quently, nasopharyngeal carcinoma and infectious mononucleosis have been linked etiologically with the virus. During the first decade of research following the discovery of the virus, the mechanisms for the induction of BL, NPC, and IM were sought. At that time one prevailing view was that individual oncogenic strains of EBV were responsible for the different disorders. Paralleling the development of immunology in the 1970's was the accrual of knowledge about immunological events occurring during IM. These studies suggest that immune defense mechanisms deter mine the outcome of this viral infection rather than different viral strains. During the early 1970's, Starzl and Penn and Gatti and Good had noted an increased frequency of malignancy in renal allograft recipients and children with primary immune deficiency disorders, respectively. These observations provoked investigators to restudy the role of immune surveillance against malignancy. At that time immune surveillance was thought to occur against tumor-specific antigens; thereby neoplasms were eliminated.
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
Neu kaufen
Diesen Artikel anzeigen
EUR 48,15
EUR 7,63 für den Versand innerhalb von/der USA
Versandziele, Kosten & DauerWeitere beliebte Ausgaben desselben Titels
Suchergebnisse für Immune Deficiency and Cancer: Epstein-Barr Virus and...
Beispielbild für diese ISBN
Immune Deficiency and Cancer
Verlag:
Plenum Medical Book Co., New York, 1984
ISBN 10: 1468447629
ISBN 13: 9781468447620
Gebraucht
Hardcover
Erstausgabe
Signiert
Anbieter: Abacus Bookshop, Pittsford, NY, USA
Verkäuferbewertung 5 von 5 Sternen
hardcover. Zustand: Very good copy. 1st. Tall 8vo, 488 pp., Inscribed & signed by the editor on the title page. Bestandsnummer des Verkäufers 115677
Anzahl: 1 verfügbar
Beispielbild für diese ISBN
Immune Deficiency and Cancer: Epstein-Barr Virus and Lymphoproliferative Malignancies
Anbieter: Best Price, Torrance, CA, USA
Verkäuferbewertung 5 von 5 Sternen
Zustand: New. SUPER FAST SHIPPING. Bestandsnummer des Verkäufers 9781468447620
Anzahl: 2 verfügbar
Beispielbild für diese ISBN
Immune Deficiency and Cancer: Epstein-Barr Virus and Lymphoproliferative Malignancies
Anbieter: Lucky's Textbooks, Dallas, TX, USA
Verkäuferbewertung 5 von 5 Sternen
Zustand: New. Bestandsnummer des Verkäufers ABLIING23Mar2716030068867
Anzahl: Mehr als 20 verfügbar
Foto des Verkäufers
Immune Deficiency and Cancer
Verlag:
Springer US, Chapman And Hall/CRC Mär 2012, 2012
ISBN 10: 1468447629
ISBN 13: 9781468447620
Neu
Taschenbuch
Anbieter: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Deutschland
Verkäuferbewertung 5 von 5 Sternen
Taschenbuch. Zustand: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The discoveries of Burkitt, Epstein, and Henle have laid the foundation for continuing generation of information regarding the mechanisms of induction of diseases by Epstein-Barr virus. The discovery of the virus two decades ago resulted from clinical and basic science collaborative studies on Burkitt lymphoma. Subse quently, nasopharyngeal carcinoma and infectious mononucleosis have been linked etiologically with the virus. During the first decade of research following the discovery of the virus, the mechanisms for the induction of BL, NPC, and IM were sought. At that time one prevailing view was that individual oncogenic strains of EBV were responsible for the different disorders. Paralleling the development of immunology in the 1970's was the accrual of knowledge about immunological events occurring during IM. These studies suggest that immune defense mechanisms deter mine the outcome of this viral infection rather than different viral strains. During the early 1970's, Starzl and Penn and Gatti and Good had noted an increased frequency of malignancy in renal allograft recipients and children with primary immune deficiency disorders, respectively. These observations provoked investigators to restudy the role of immune surveillance against malignancy. At that time immune surveillance was thought to occur against tumor-specific antigens; thereby neoplasms were eliminated. 504 pp. Englisch. Bestandsnummer des Verkäufers 9781468447620
Anzahl: 2 verfügbar
Beispielbild für diese ISBN
Immune Deficiency and Cancer
Anbieter: Books Puddle, New York, NY, USA
Verkäuferbewertung 4 von 5 Sternen
Zustand: New. pp. 504. Bestandsnummer des Verkäufers 2697852250
Anzahl: 4 verfügbar
Beispielbild für diese ISBN
Immune Deficiency and Cancer
Print-on-DemandAnbieter: Majestic Books, Hounslow, Vereinigtes Königreich
Verkäuferbewertung 5 von 5 Sternen
Zustand: New. Print on Demand pp. 504 66:B&W 7 x 10 in or 254 x 178 mm Perfect Bound on White w/Gloss Lam. Bestandsnummer des Verkäufers 94545029
Anzahl: 4 verfügbar
Beispielbild für diese ISBN
Immune Deficiency and Cancer: Epstein-Barr Virus and Lymphoproliferative Malignancies
Verlag:
Springer-Verlag New York Inc., 2012
ISBN 10: 1468447629
ISBN 13: 9781468447620
Neu
Paperback / softback
Anbieter: THE SAINT BOOKSTORE, Southport, Vereinigtes Königreich
Verkäuferbewertung 5 von 5 Sternen
Paperback / softback. Zustand: New. This item is printed on demand. New copy - Usually dispatched within 5-9 working days 897. Bestandsnummer des Verkäufers C9781468447620
Anzahl: Mehr als 20 verfügbar
Beispielbild für diese ISBN
Immune Deficiency and Cancer
Print-on-DemandAnbieter: Biblios, Frankfurt am main, HESSE, Deutschland
Verkäuferbewertung 5 von 5 Sternen
Zustand: New. PRINT ON DEMAND pp. 504. Bestandsnummer des Verkäufers 1897852240
Anzahl: 4 verfügbar
Foto des Verkäufers
Immune Deficiency and Cancer
Print-on-DemandAnbieter: moluna, Greven, Deutschland
Verkäuferbewertung 5 von 5 Sternen
Zustand: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. The discoveries of Burkitt, Epstein, and Henle have laid the foundation for continuing generation of information regarding the mechanisms of induction of diseases by Epstein-Barr virus. The discovery of the virus two decades ago resulted from clinical and b. Bestandsnummer des Verkäufers 4203977
Anzahl: Mehr als 20 verfügbar
Foto des Verkäufers
Immune Deficiency and Cancer
Verlag:
Springer US, Springer New York Mär 2012, 2012
ISBN 10: 1468447629
ISBN 13: 9781468447620
Neu
Taschenbuch
Anbieter: buchversandmimpf2000, Emtmannsberg, BAYE, Deutschland
Verkäuferbewertung 5 von 5 Sternen
Taschenbuch. Zustand: Neu. This item is printed on demand - Print on Demand Titel. Neuware -The discoveries of Burkitt, Epstein, and Henle have laid the foundation for continuing generation of information regarding the mechanisms of induction of diseases by Epstein-Barr virus. The discovery of the virus two decades ago resulted from clinical and basic science collaborative studies on Burkitt lymphoma. Subse quently, nasopharyngeal carcinoma and infectious mononucleosis have been linked etiologically with the virus. During the first decade of research following the discovery of the virus, the mechanisms for the induction of BL, NPC, and IM were sought. At that time one prevailing view was that individual oncogenic strains of EBV were responsible for the different disorders. Paralleling the development of immunology in the 1970's was the accrual of knowledge about immunological events occurring during IM. These studies suggest that immune defense mechanisms deter mine the outcome of this viral infection rather than different viral strains. During the early 1970's, Starzl and Penn and Gatti and Good had noted an increased frequency of malignancy in renal allograft recipients and children with primary immune deficiency disorders, respectively. These observations provoked investigators to restudy the role of immune surveillance against malignancy. At that time immune surveillance was thought to occur against tumor-specific antigens; thereby neoplasms were eliminated.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 504 pp. Englisch. Bestandsnummer des Verkäufers 9781468447620
Anzahl: 1 verfügbar